CDKN2B-AS1 and lung carcinoma: Researchers found a significant inverse relationship between lncRNA ANRIL and miR-98 in lung cancer cells, demonstrating that suppressing ANRIL increases miR-98 expression, preventing cisplatin resistance [114].